Evidence map›Paper›PMID 31857291›Full record

ArticleBMJ case reports2019

Type 2 diabetes mellitus complicated with idiopathic hypoparathyroidism where poor glycaemic control was associated with low adherence to exercise and medication due to hypocalcaemia.

Tomomi Ueda, Yuya Tsurutani, Sho Katsuragawa, Jun Saito

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tomomi UedaEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan.
Yuya TsurutaniEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan yuya97tsuru1055@gmail.com.ORCID http://orcid.org/0000-0001-5831-3286
Sho KatsuragawaEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan.
Jun SaitoEndocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan.
Yokohama Rosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a rare case of type 2 diabetes mellitus (T2DM) complicated with idiopathic hypoparathyroidism. A 36-year-old Japanese man was admitted to our hospital owing to poor glycaemic control and hypocalcaemia. The patient had myalgia resulting from hypocalcaemia, which prevented adequate exercise. He considered the onset of myalgia to be an adverse event of oral hypoglycaemic agents and reduced compliance to medication; however, his serum calcium level was never measured. Treatment for hypocalcaemia immediately improved the myalgia, facilitating regular exercise therapy and ensuring compliance with prescribed medications, as the now-resolved myalgia was no longer perceived to be an adverse effect of glucose-lowering agents; this improved glycaemic control. Although hypoparathyroidism is a rare disease, it is necessary to assess serum calcium levels in patients with T2DM, particularly in cases presenting with unidentified complaints such as myalgia.

Indexed as

AdultBlood GlucoseCalcitriolCombined Modality TherapyDiabetes Mellitus, Type 2Diagnosis, DifferentialExercise TherapyGlycated HemoglobinHumansHypocalcemiaHypoglycemic AgentsHypoparathyroidismMaleMyalgiaBlood GlucoseCalcitriolGlycated HemoglobinHypoglycemic Agentscalcium and bonediabetes

Identifiers

PMID31857291
PMCPMC6936438
OpenAlexW2995835092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.